Aquestive Therapeutics, Inc.

AQSTSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1398733

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$57.6M	$50.6M	$47.7M	$50.8M	$45.8M
Cost of Goods and Services Sold	$17.9M	$20.8M	$19.4M	—	—
Research and Development Expense	$20.3M	$13.1M	$17.5M	$17.0M	$19.9M
Selling, General and Administrative Expense	$50.2M	$31.8M	$52.9M	$53.5M	$55.9M
Operating Expenses	—	—	—	$85.5M	$88.7M
Operating Income (Loss)	-$30.8M	-$15.1M	-$42.1M	-$34.7M	-$42.9M
Interest Expense	—	—	$6.6M	$10.0M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$101.4M	$57.4M	$57.1M	$62.0M	$62.9M
Assets, Current	$88.2M	$41.0M	$39.9M	$47.3M	$44.6M
Cash and Cash Equivalents, at Carrying Value	—	—	—	—	—
Inventory, Net	$6.0M	$6.8M	$5.8M	$4.0M	$2.5M
Liabilities	$161.6M	$163.9M	$175.6M	$144.1M	$111.4M
Liabilities, Current	$18.9M	$18.3M	$39.5M	$22.0M	$21.1M
Long-term Debt	$45.0M	$45.0M	$45.0M	—	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$35.8M	-$6.4M	-$9.8M	-$33.0M	-$45.5M
Net Cash Provided by (Used in) Investing Activities	-$159.0K	-$995.0K	-$2.5M	-$913.0K	-$517.0K
Net Cash Provided by (Used in) Financing Activities	$83.6M	$4.0M	$11.6M	$30.1M	$28.5M
Payments to Acquire Property, Plant, and Equipment	$159.0K	$995.0K	$1.0M	$913.0K	$517.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)